@article{83f87a4c6c9047a097988c547f6e75f5,
title = "Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial",
author = "Langley, {Joanne M.} and Louise Frenette and Robert Jeanfreau and Halperin, {Scott A.} and Michael Kyle and Laurence Chu and Shelly McNeil and Mamadou Dram{\'e} and Philippe Moris and Louis Fries and Vaughn, {David W.}",
note = "Funding Information: The study was funded by GlaxoSmithKline Biologicals SA and the Biomedical Advanced Research and Development Authority (BARDA) grant number HHSO100200700029C, United States Department of Health and Human Services. GlaxoSmithKline Biologicals SA was involved in all stages of the study conduct and analysis. GlaxoSmithKline Biologicals SA also took in charge all costs associated with the development and the publishing of the present manuscript. All authors had full access to the data. The corresponding author had final responsibility to submit for publication. Publisher Copyright: {\textcopyright} 2014 The Authors.",
year = "2015",
month = jan,
day = "15",
doi = "10.1016/j.vaccine.2014.11.018",
language = "English",
volume = "33",
pages = "559--567",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "4",
}
